Eli Lilly & Co. vs Revolution Medicines, Inc.
LLY vs RVMD — side-by-side comparison from reported financials. LLY leads 4, RVMD leads 2 of 6 comparable metrics.
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
Revolution Medicines, Inc.
RVMD · Healthcare
$189.76+0.87%Mixed
| Metric | LLY | RVMD |
|---|---|---|
| Price | $1 177.20 | $189.76 |
| Market cap | $1.05T | $40.7B |
| Revenue (TTM) | $79.7B | $0 |
| Revenue growth | +31.7% | — |
| Net margin | 33.5% | — |
| Free cash flow | $18.2B | -$2.65B |
| Net cash (debt) | ($35.2B) | $2.75B |
| 1-year price return | +37.6% | +298.5% |
| P/E | 41.6 | — |
| P/E vs own history (cheap-side %) | 88% | — |
| Dividend yield | 0.52% | — |
| Return on equity | 93% | -54% |
| Altman Z-score | 7.10 | — |
| CV checks passed | 11 of 11 | 3 of 11 |
| Employees | 50,000 | 883 |
Full résumé-style profiles: LLY CV · RVMD CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.